In around 90 percent of PsA cases, the joint symptoms only appear after the skin manifestations. Scientific studies have shown that a delayed PsA diagnosis can have unfavorable prognostic implications. Recently published consensus recommendations therefore suggest that patients with plaque psoriasis should be screened for joint involvement once or twice a year. Various screening methods can be combined.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- Omaveloxolone for Friedreich's Ataxia
Efficacy and Safety Studied Over 6 Years
- Psoriasis: therapy with biologics and TYK-2-i
Progress assessments based on current long-term and real-world data
- Hypertension: the most important facts for daily practice
Early dual antihypertensive therapy is usually indicated
- Escitalopram for anxiety disorders
Positive effect, but no immediate improvement in symptoms
- Helicobacter pylori infection
Simplified dual therapy beats quadruple regimen
- Gastric carcinoma
Ways of precision oncology
- Endometrial Cancer
Immunological drivers and new therapeutic pathways
- Exercise for type 1 diabetes